Zobrazeno 1 - 3
of 3
pro vyhledávání: '"George Spentzouris"'
Autor:
Artak Khachatryan, Indraraj Umesh Doobaree, George Spentzouris, Gaelle Gusto, Yousef Zawaneh, Farhan Mughal, Anastassia Anastassopoulou, Marius Manu, Matthew Fay
Publikováno v:
Advances in therapy.
Per-label dosing of direct oral anticoagulants (DOACs) is important for the prevention of stroke and systemic embolism among patients with non-valvular atrial fibrillation (NVAF), especially those with poor renal function, advanced age, low body weig
Autor:
Elisabeth Smits, Felicita Andreotti, Eline Houben, Harry J. G. M. Crijns, Sylvia Haas, George Spentzouris, Tania Schink, Rosa Gini, Claudia Bartolini, Fernie Penning-van Beest, Ron Herings
Publikováno v:
Drugs-Real World Outcomes, 9(2), 199-209. Springer International Publishing AG
Smits, E, Andreotti, F, Houben, E, Crijns, H J G M, Haas, S, Spentzouris, G, Schink, T, Gini, R, Bartolini, C, Penning-van Beest, F & Herings, R 2022, ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation : Real-World Analyses from the Netherlands, Italy and Germany ', Drugs-Real World Outcomes, vol. 9, no. 2, pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w
Drugs-real world outcomes, 9(2):199–209
Drugs-Real World Outcomes, 9(2), 199-209. Adis International Ltd
Smits, E, Andreotti, F, Houben, E, Crijns, H J G M, Haas, S, Spentzouris, G, Schink, T, Gini, R, Bartolini, C, Penning-van Beest, F & Herings, R 2022, ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation : Real-World Analyses from the Netherlands, Italy and Germany ', Drugs-Real World Outcomes, vol. 9, no. 2, pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w
Drugs-real world outcomes, 9(2):199–209
Drugs-Real World Outcomes, 9(2), 199-209. Adis International Ltd
Background Direct oral anticoagulants are available for patients with atrial fibrillation. Objective This study compared adherence and persistence of once-daily (QD) vs twice-daily (BID) direct oral anticoagulants in patients with atrial fibrillation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a3a6bd049eb0949b2fbc74da950505f
https://research.vumc.nl/en/publications/95904649-183e-43f9-b624-d7201237d612
https://research.vumc.nl/en/publications/95904649-183e-43f9-b624-d7201237d612
Autor:
Emily Holthuis, Elisabeth Smits, George Spentzouris, Dominik Beier, Dirk Enders, Rosa Gini, Claudia Bartolini, Giampiero Mazzaglia, Fernie Penning-van Beest, Ron Herings
Publikováno v:
Holthuis, E, Smits, E, Spentzouris, G, Beier, D, Enders, D, Gini, R, Bartolini, C, Mazzaglia, G, Penning-van Beest, F & Herings, R 2022, ' Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs) : Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany ', Drugs-Real World Outcomes, vol. 9, no. 4, pp. 597-607 . https://doi.org/10.1007/s40801-022-00317-3
Drugs-Real World Outcomes, 9(4), 597-607. Springer International Publishing AG
Drugs-Real World Outcomes, 9(4), 597-607. Springer International Publishing AG
Background: A high degree of adherence to direct oral anticoagulants is essential for reducing the risk of ischaemic stroke and systemic embolism in patients with atrial fibrillation, owing to the rapid decline in anticoagulation activity when doses